David B Meya

Infectiology — Makerere University, Uganda

LeadR Profile

David B Meya Makerere University Uganda
1 211 ScienceLeadR Reputation 1211
Network Map

Infectiology

Subspecialties: Neurology - Public Health - Immunology

Full career Last 3 years

Main Topics

Publications and Clinical Studies

Publications Clinical Studies

Organizations

Source: Pubmed

Makerere University

Publications Synthesis

Source: Pubmed

Number : 356

Citations

Citations: 8 849 1st author: 18 Last author: 46 Unique author: 1

Main journals

Open Forum Infect Dis 53
Clin Infect Dis 31
PLoS One 20
Med Mycol 14
J Acquir Immune Defic Syndr 13

Best Journals

N Engl J Med 6
Lancet Infect Dis 4
Lancet Glob Health 1

Breakdown by type

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis.
cytokines, interferon-gamma, cells, mortality, tuberculosis, meningeal, adrenal cortex hormones, meningitis, hiv, immunity, therapeutics, communicable diseases
J Infect Dis20260
Evaluating Desirability of Outcome Ranking (DOOR) and Win Ratio for Hierarchical Composite Endpoints in Cryptococcal Meningitis Trials.
mortality, meningitis, drug-related side effects and adverse reactions, meningitis, cryptococcal, amphotericin b, sertraline, therapeutics, communicable diseases, data interpretation, statistical
Clin Infect Dis20260
A cluster randomized trial of Visitect CD4 Advanced Disease platform among outpatients with advanced HIV disease in Uganda.
cells, research design, opportunistic infections, point-of-care systems, acquired immunodeficiency syndrome, hiv, therapeutics, retention, psychology, outpatients
J Int AIDS Soc20260
Headache as a Predictor of Cryptococcal Meningitis in Ambulatory Patients With Symptomatic HIV-associated Cryptococcal Antigenemia.
headache, cryptococcosis, confusion, classification, meningitis, signs and symptoms, photophobia, hiv, meningitis, cryptococcal
Open Forum Infect Dis20260
Prevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort Study.
cohort studies, meningitis, hiv, prevalence
Open Forum Infect Dis20260

Clinical Studies 11

Source: ClinicalTrials

Synthesis

Principal Investigator: 3

By phase:

N/A 2
Phase 2 2
Phase 2/Phase 3 2
Phase 3 2
Phase 4 2
Phase 1/Phase 2 1

By status:

Completed 7
Recruiting 2
Not yet recruiting 1
Unknown 1

By type:

Interventional 10
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 6
multicentric5to9 0
multicentricup10 0

Main Topics

Nervous System Diseases 9

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Platform Trial For Cryptococcal Meningitis
NCT06666322 — injections, mortality, pharmaceutical preparations, fluconazole, sterols, flucytosine, meningitis, acquired immunodeficiency syndrome, hiv, meningitis, cryptococcal, azoles, amphotericin b, therapeutics, infections
Phase 2/Phase 3Recruiting2025
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3
NCT05541107 — meningitis, meningitis, cryptococcal, amphotericin b
Phase 3Not yet recruiting2023

LeadR Networks

Main global connection map

Source: Pubmed Source: ClinicalTrials